MET and cancer: This central role is largely attributed to aberrant c-MET/HGF signaling, which derives epithelial-to-mesenchymal transition, enhances cancer cell migration and invasion, stimulates angiogenesis through VEGF cross-talk, and contributes to chemoresistance, hallmarks frequently observed in TNBC.